ArticleBMC cancer2020

Tumor infiltrating immune cells (TIICs) as a biomarker for prognosis benefits in patients with osteosarcoma.

Ying Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.